• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How to choose duration of additional androgen deprivation therapy with salvage radiation therapy: short, long, more, or none?

作者信息

Aragon-Ching Jeanny B

机构信息

GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA 22031, USA.

出版信息

Asian J Androl. 2025 Sep 1;27(5):553-555. doi: 10.4103/aja202521. Epub 2025 May 16.

DOI:10.4103/aja202521
PMID:40384109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12422566/
Abstract
摘要

相似文献

1
How to choose duration of additional androgen deprivation therapy with salvage radiation therapy: short, long, more, or none?如何选择挽救性放射治疗时额外雄激素剥夺治疗的持续时间：短、长、更长还是不进行？
Asian J Androl. 2025 Sep 1;27(5):553-555. doi: 10.4103/aja202521. Epub 2025 May 16.
2
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分：晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
3
Matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC.恩杂鲁胺与达罗他胺双重疗法在转移性去势敏感性前列腺癌中的匹配调整间接比较
Future Oncol. 2025 Aug;21(19):2459-2469. doi: 10.1080/14796694.2025.2526324. Epub 2025 Jul 14.
4
Duration of androgen deprivation therapy with salvage radiotherapy in patients with prostate cancer and biochemical recurrence after surgery: Initial recruitment data in the phase III URONCOR 06-24 trial.前列腺癌术后生化复发患者接受挽救性放疗时雄激素剥夺治疗的持续时间：III期URONCOR 06-24试验的初始招募数据。
Actas Urol Esp (Engl Ed). 2025 Sep;49(7):501823. doi: 10.1016/j.acuroe.2025.501823. Epub 2025 Jul 31.
5
Intensity modulated radiation therapy in prostate cancer-Better survival with higher total dose?前列腺癌的调强放射治疗——更高的总剂量能带来更好的生存效果吗？
Strahlenther Onkol. 2025 Apr 10. doi: 10.1007/s00066-025-02392-1.
6
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature.根治性或挽救性局部治疗后复发性前列腺癌的一线全身治疗：文献系统评价。
Eur Urol Oncol. 2022 Aug;5(4):377-387. doi: 10.1016/j.euo.2022.04.009. Epub 2022 May 28.
7
Salvage prostate bed plus elective pelvic node radiation without androgen deprivation therapy.挽救性前列腺床加选择性盆腔淋巴结放疗，不进行雄激素剥夺治疗。
J Cancer Res Clin Oncol. 2023 Nov;149(14):13231-13237. doi: 10.1007/s00432-023-05085-3. Epub 2023 Jul 22.
8
Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.系统评价：临床局限性前列腺癌治疗方法的比较效果与危害
Ann Intern Med. 2008 Mar 18;148(6):435-48. doi: 10.7326/0003-4819-148-6-200803180-00209. Epub 2008 Feb 4.
9
PSA provocation by bipolar androgen therapy may predict duration of response to first-line androgen deprivation: Updated results from the BATMAN study.双相雄激素治疗引起的 PSA 升高可能预测一线雄激素剥夺治疗的反应持续时间：BATMAN 研究的更新结果。
Prostate. 2022 Dec;82(16):1529-1536. doi: 10.1002/pros.24426. Epub 2022 Aug 8.
10
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115).
Int J Radiat Oncol Biol Phys. 2025 Jul 23. doi: 10.1016/j.ijrobp.2025.07.1425.

本文引用的文献

1
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.在前列腺癌术后放疗中添加 6 个月雄激素剥夺治疗：RADICALS-HD 随机对照试验中短程与无雄激素剥夺治疗的比较。
Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16.
2
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.根治性放疗联合不同时长雄激素剥夺治疗前列腺癌的随机临床试验（RADICALS-HD）：长程与短程雄激素剥夺治疗的比较。
Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16.
3
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.醋酸阿比特龙、前列腺床放疗和促黄体生成素释放激素激动剂联合用于前列腺切除术后生化复发患者（CARLHA）：一项2期临床试验。
Eur Urol Oncol. 2025 Feb;8(1):38-46. doi: 10.1016/j.euo.2024.04.014. Epub 2024 May 11.
4
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy.前列腺癌挽救性治疗：AUA/ASTRO/SUO 指南第 I 部分：根治性前列腺切除术后疑似生化复发时的介绍和治疗决策。
J Urol. 2024 Apr;211(4):509-517. doi: 10.1097/JU.0000000000003892. Epub 2024 Feb 29.
5
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
6
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.根治性前列腺切除术后高风险前列腺特异性抗原复发前列腺癌的挽救性放疗加恩扎鲁胺或安慰剂的 II 期随机研究：SALV-ENZA 试验。
J Clin Oncol. 2023 Feb 20;41(6):1307-1317. doi: 10.1200/JCO.22.01662. Epub 2022 Nov 11.
7
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' reply.盆腔淋巴结治疗在前列腺床挽救性放疗中的应用——作者回复
Lancet. 2022 Sep 17;400(10356):885-886. doi: 10.1016/S0140-6736(22)01434-9.
8
RADICALS-HD: Reflections before the Results are Known.RADICALS-HD：在结果知晓之前的思考。
Clin Oncol (R Coll Radiol). 2022 Sep;34(9):593-597. doi: 10.1016/j.clon.2022.06.004. Epub 2022 Jul 6.
9
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.在根治性前列腺切除术后未接受激素治疗的患者中接受挽救性放疗时，验证 Decipher 基因组分类器- SAKK 09/10 随机临床试验的辅助研究。
Ann Oncol. 2022 Sep;33(9):950-958. doi: 10.1016/j.annonc.2022.05.007. Epub 2022 May 28.
10
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.雄激素剥夺治疗和盆腔淋巴结治疗联合前列腺床挽救性放疗（NRG Oncology/RTOG 0534 SPORT）：一项国际、多中心、随机 3 期试验。
Lancet. 2022 May 14;399(10338):1886-1901. doi: 10.1016/S0140-6736(21)01790-6.